Author:
Shen Kai,Ma Xuelei,Zhu Chenjing,Wu Xin,Jia Hongyuan
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Sharp, A. & Johnston, S. R. Dose-reduced trastuzumab emtansine: active and safe in acute hepatic dysfunction. Case Rep Oncol. 8, 113–121 (2015).
2. Breast Cancer Statistics. Available at:
http://www.breastcancer.org/symptoms/understand_bc/statistics
(Accessed May 11, 2015).
3. Tinoco, G., Warsch, S., Gluck, S., Avancha, K. & Montero, A. J. Treating breast cancer in the 21st century: emerging biological therapies. J Cancer. 4, 117–132 (2013).
4. Sharp, A. & Harper-Wynne, C. Treatment of advanced breast cancer (ABC): the expanding landscape of targeted therapies. J Cancer Biol Res. 2, 1036 (2014).
5. Eggemann, H. et al. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer. Endocr Relat Cancer. 22, 725–733 (2015).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献